Evidence map›Paper›PMID 25118285›Full record

ArticleThe Journal of biological chemistry2014

Ubiquitin-specific protease 7 regulates nucleotide excision repair through deubiquitinating XPC protein and preventing XPC protein from undergoing ultraviolet light-induced and VCP/p97 protein-regulated proteolysis.

Jinshan He, Qianzheng Zhu, Gulzar Wani, Nidhi Sharma, Chunhua Han, Jiang Qian, Kyle Pentz, Qi-En Wang, Altaf A Wani

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 86 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. ATAD5 functions as a regulatory platform for Ub-PCNA deubiquitination.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Deubiquitylating Enzymes in Cancer and Immunity.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Jinshan HeDepartment of Radiology, The Ohio State University, Columbus, Ohio 43210.
Qianzheng ZhuDepartment of Radiology, The Ohio State University, Columbus, Ohio 43210. Electronic address: zhu.49@osu.edu.
Gulzar WaniDepartment of Radiology, The Ohio State University, Columbus, Ohio 43210.
Nidhi SharmaDepartment of Radiology, The Ohio State University, Columbus, Ohio 43210.
Chunhua HanDepartment of Radiology, The Ohio State University, Columbus, Ohio 43210.
Jiang QianDepartment of Radiology, The Ohio State University, Columbus, Ohio 43210.
Kyle PentzDepartment of Radiology, The Ohio State University, Columbus, Ohio 43210.
Qi-En WangDepartment of Radiology, The Ohio State University, Columbus, Ohio 43210.
Altaf A WaniDepartment of Radiology, The Ohio State University, Columbus, Ohio 43210; Department of Molecular and Cellular Biochemistry, and The Ohio State University, Columbus, Ohio 43210; James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio 43210. Electronic address: wani.2@osu.edu.
The Ohio State University · USThe Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute · US

Funding

Cross-talking pre-incision events of eukaryotic NERR01ES012991 · NIEHS · OHIO STATE UNIVERSITY · PI WANI, ALTAF A, ZHU, QIANZHENG · 2004 to 2020
$6.2M
DNA DAMAGE RESPONSES FOLLOWING GENOTOXIN EXPOSURER01ES002388 · NIEHS · OHIO STATE UNIVERSITY · PI WANI, ALTAF A · 1985 to 2016
$4.9M
NIEHS NIH HHS ES12991NIEHS NIH HHS ES2388NIEHS NIH HHS R01 ES002388NIEHS NIH HHS R01 ES012991
6 · The paper itself

Abstract

Ubiquitin specific protease 7 (USP7) is a known deubiquitinating enzyme for tumor suppressor p53 and its downstream regulator, E3 ubiquitin ligase Mdm2. Here we report that USP7 regulates nucleotide excision repair (NER) via deubiquitinating xeroderma pigmentosum complementation group C (XPC) protein, a critical damage recognition factor that binds to helix-distorting DNA lesions and initiates NER. XPC is ubiquitinated during the early stage of NER of UV light-induced DNA lesions. We demonstrate that transiently compromising cellular USP7 by siRNA and chemical inhibition leads to accumulation of ubiquitinated forms of XPC, whereas complete USP7 deficiency leads to rapid ubiquitin-mediated XPC degradation upon UV irradiation. We show that USP7 physically interacts with XPC in vitro and in vivo. Overexpression of wild-type USP7, but not its catalytically inactive or interaction-defective mutants, reduces the ubiquitinated forms of XPC. Importantly, USP7 efficiently deubiquitinates XPC-ubiquitin conjugates in deubiquitination assays in vitro. We further show that valosin-containing protein (VCP)/p97 is involved in UV light-induced XPC degradation in USP7-deficient cells. VCP/p97 is readily recruited to DNA damage sites and colocalizes with XPC. Chemical inhibition of the activity of VCP/p97 ATPase causes an increase in ubiquitinated XPC on DNA-damaged chromatin. Moreover, USP7 deficiency severely impairs the repair of cyclobutane pyrimidine dimers and, to a lesser extent, affects the repair of 6-4 photoproducts. Taken together, our findings uncovered an important role of USP7 in regulating NER via deubiquitinating XPC and by preventing its VCP/p97-regulated proteolysis.

Indexed as

Ultraviolet RaysAdenosine TriphosphatasesCell Cycle ProteinsDNA-Binding ProteinsDNA DamageDNA RepairHeLa CellsHumansMutationProteolysisPyrimidine DimersUbiquitinationUbiquitin-Specific Peptidase 7Ubiquitin ThiolesteraseValosin Containing ProteinAdenosine TriphosphatasesCell Cycle ProteinsDNA-Binding ProteinsPyrimidine DimersUbiquitin-Specific Peptidase 7Ubiquitin ThiolesteraseUSP7 protein, humanValosin Containing ProteinVCP protein, humanXPC protein, humanDeubiquitylation (Deubiquitination)DNA Damage ResponseDNA RepairNucleotide Excision RepairUbiquitin-specific Protease 7Ubiquitylation (Ubiquitination)Valosin-containing ProteinXeroderma Pigmentosum Complementation Group C Protein

Identifiers

PMID25118285
PMCPMC4175359
OpenAlexW1968028576

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.